October 5, 2017

Mugaritz and the BCBL will collaborate in a scientific study to discover the cerebral bases of creativity

By | Mugaritz y BCBL investigan las bases de la creatividad

The chef’s brain will be observed to see if during the creative process of Mugaritz- from January to April- they undergo any change and which cerebral regions are activated when different culinary solutions are improvised

The research seeks to expand knowledge on the creative process from the cognitive neuroscience perspective, a somewhat unchartered phenomenon

Ver artículo
July 7, 2015

New pharmacological therapies for treating the most aggressive form of porphyria

By | Grupo de investigación

Research led by the Center for Cooperative Research in Biosciences seeks to obtain effective methods for changing the stability of the enzyme that causes development of congenital erythropoietic porphyria.

The research, which has received financial assistance from the multinational pharmaceutical company, Merck Serono, is focused on the use of pharmacological chaperones.

Ver artículo
June 17, 2015

Healing tears

By | Equipo bioGUNE

CIC bioGUNE and the company Bioftalmik have been working on a project that has identified a broad catalogue of endogenous peptides in human tears, and some of them have antimicrobial properties

This research, published in the Journal of Proteome Research, can lead to the study of the application of human peptides in the treatment of inflammatory processes and wound healing

Ver artículo
March 27, 2015

Which wine do you prefer? Ask your brain!

By | Wine by Khawkins04 on Flickr

The Basque research center BCBL has lead the first study on the brain’s functional response to wine consumption

The study, published in the prestigious journal Plos One and conducted in collaboration with the Basque Culinary Center, seeks to build bridges between the wine production world and cutting edge scientific research

The experiment found that the brain derives more pleasure from wines with a lower alcohol content

Ver artículo
November 20, 2014

Study discovers how rare disease causing cardiovascular and cognitive disorders is triggered

By | Proteína

This rare disease is homocystinuria, which affects 1 in every 250,000 children born in Spain and has recently been included in neonatal screening

A study conducted by CIC bioGUNE and the University of Colorado (US) has discovered the three-dimensional structure of the main protein involved in this disease

Knowing the 3D structure of the protein will enable the design of drugs to fight this disease, which currently has no cure

Ver artículo
October 2, 2014

The first non-invasive test to diagnose fatty liver disease is awarded two patents in the US

By | Test higado graso

The diagnostic test, which correctly categorises the disease in 94% of patients, is already being marketed as Owl Liver by the Basque company Owl.

The company will start to market the test in Brazil and Mexico in the autumn, and has signed an agreement with the University of Virginia, in the US.

Pablo Ortiz, CEO of Owl, considers it to be “the most accurate non-invasive diagnosis test”. 

Ver artículo